Insulin Delivery Device Market - Global Forecast to 2030
商品番号 : SMB-39941
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年6月 |
| ページ数 | 379 |
| 図表数 | 519 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
本レポートは、インスリン送達デバイス市場を、種類、疾患、エンドユーザー、地域の観点から分析しています。また、市場の成長に影響を与える要因（促進要因、制約要因、機会、課題など）を分析するとともに、市場リーダー企業の競争環境の詳細も提供しています。さらに、マイクロマーケットを個々の成長傾向に基づいて分析し、5つの主要地域（および各地域に属する国）における市場セグメントの収益予測も提供しています。
The global insulin delivery devices market is projected to reach USD 52.7 billion by 2030 from USD 35.3 billion in 2025, at a CAGR of 8.3% during the forecast period. The insulin delivery devices market is experiencing consistent growth due to several factors. As the global population ages, the prevalence of conditions like diabetes is rising, leading to an increased demand for advanced insulin delivery devices. Additionally, government support and favorable reimbursement schemes are further promoting market growth.
世界のインスリン送達デバイス市場は、2025年の353億米ドルから2030年には527億米ドルに達し、予測期間中は年平均成長率（CAGR）8.3%で成長すると予測されています。インスリン注入デバイス市場は、いくつかの要因により着実な成長を遂げています。世界的な人口高齢化に伴い、糖尿病などの疾患の有病率も上昇しており、高度なインスリン注入デバイスに対する需要が高まっています。さらに、政府の支援と有利な償還制度も市場の成長をさらに促進しています。
Technological advancements in insulin delivery devices, such as the integration of artificial intelligence (AI) and machine learning (ML), have also contributed to this demand. Furthermore, an increase in research and development activities, along with strategic partnerships, is creating additional opportunities for growth in the market.
インスリン送達デバイスにおける人工知能（AI）と機械学習（ML）の統合といった技術進歩も、この需要の増加に貢献しています。さらに、研究開発活動の増加と戦略的パートナーシップの強化が、市場の成長機会をさらに創出しています。
Overall, the rise in healthcare expenditure focused on diabetes care, combined with the increasing prevalence of diabetes, is fostering new opportunities for market expansion.
The reusable insulin pens segment accounted for the largest share of the insulin delivery devices market, by type of insulin pen, in 2024.
The insulin delivery devices market can be categorized into several types: insulin pens, insulin pumps, insulin syringes, insulin pen needles, and other insulin delivery devices. Within the category of insulin pens, there are two main types: reusable insulin pens and disposable insulin pens. As of 2024, reusable insulin pens held the largest market share.
Reusable insulin pens feature a delivery chamber designed to hold prefilled insulin cartridges. These devices are more cost-effective than disposable insulin pens, leading to their increasing popularity for insulin delivery. They provide significant advantages in terms of affordability, sustainability, and user-friendliness. Additionally, reusable pens offer environmental benefits.
A recent study from the University of Exeter in 2024 reported that approximately four million single-use insulin pens are prescribed annually in England, resulting in about 79 tons of plastic waste and emitting 1,000 tons of carbon dioxide, which is equivalent to the emissions from 250 additional cars on the road. In contrast, reusable insulin pens can significantly reduce this waste, making them a more sustainable option. Consequently, a growing number of end users are opting for reusable insulin pens, driving the segment’s growth.
In 2024, the home care settings segment held the largest share of the insulin delivery devices market.
The insulin delivery devices market is categorized by end users into home care settings, hospitals & clinics, and other end users. In 2024, the home care settings segment held the largest market share. This trend is primarily attributed to the increasing preference for self-administration of insulin among patients. One of the main advantages of self-administration is the time and cost savings it offers, as patients can avoid the need for regular visits to healthcare providers for insulin administration. Additionally, self-administration can enhance medication adherence and improve treatment outcomes.
Several factors support this trend, including the launch of advanced, user-friendly delivery devices, manufacturers’ focus on providing patient training, and the availability of reimbursements for insulin self-administration in key markets. Over the years, the market has also seen the introduction of technologically advanced pumps and pen needles designed to help patients manage diabetes through self-administration. These new products are designed to deliver precise amounts of insulin using minimally invasive techniques. Collectively, these factors are driving growth in this segment of the market.
In 2024, North America accounted for the largest share of the insulin delivery devices market.
The global market for insulin delivery devices is divided into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2024, North America accounted for the largest share of this market, primarily due to the rising prevalence of type 1 diabetes in the region. Since type 1 diabetes is dependent on insulin, the increasing number of diabetes patients is driving up demand for insulin delivery devices.
According to the International Diabetes Federation (IDF) Atlas 2025, approximately 1.4 million individuals in the US and 240,000 in Canada were reported to be living with type 1 diabetes in 2024. This growing patient population is fueling a continuous demand for various insulin delivery devices, including pens, pumps, syringes, and pen needles.
Additionally, the North American region is witnessing significant investments in research and development aimed at enhancing insulin delivery technologies. Companies in the area are actively working to improve patient convenience, accuracy, and connectivity of these devices to meet the evolving needs of healthcare professionals and patients. The combination of high disease prevalence, technological advancements, and a robust healthcare infrastructure ensures that North America remains a leading region in the global insulin delivery devices market.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1 (40%), Tier 2 (30%), and Tier 3 (30%)
- By Designation: C-level Executives (50%), Director-level Executives (30%), and Others (20%)
- By Region: North America (30%), Europe (25%), Asia Pacific (20%), Latin America (15%), and the Middle East & Africa (10%)
Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10 billion, Tier 2 = USD 1 billion to USD 10 billion, and Tier 3 = <USD 1 billion.
Note 2: C-level executives include CEOs, CFOs, COOs, and VPs.
Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
The players operating in the insulin delivery devices market include Embecta Corp.(US), Novo Nordisk A/S (Denmark), Ypsomed (Switzerland), Medtronic (Ireland), Tandem Diabetes Care, Inc. (US), Sanofi (France), and Eli Lilly and Company (US), Tandem Diabetes Care, Inc. (US), Insulet Corporation (US), Biocon (India), Roche Diabetes Care (Switzerland), HTL-STREFA, a subsidiary of the MTD Group (Poland), Ypsomed (Switzerland), Medtrum Technologies Inc. (China), Terumo Corporation (Japan), Wockhardt Limited (India), Nipro (Japan), Cequr Corporation (Switzerland), Eoflow Co., Ltd. (South Korea), Hindustan Syringes & Medical Devices Ltd. (India), SOOIL Developments Co., Ltd. (South Korea), SUNGSHIM MEDICAL CO., LTD (South Korea), B. Braun SE (Germany), Debiotech SA (Switzerland), Jiangsu Delfu Medical Device Co., Ltd. (China), Haselmeier, a Medmix company (Germany), and Mankind Corporation (US).
Research Coverage
This report studies the insulin delivery devices market based on type, disease type, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will allow both established companies and smaller or new firms to assess market trends, helping them increase their market share. Companies that purchase the report can employ one or more of the strategies outlined below to enhance their market presence.
This report provides insights on the following pointers:
- Analysis of key drivers (growing prevalence of diabetes, technological advancements in insulin delivery devices, government support, and favorable reimbursement schemes), restraints (high cost and lack of reimbursement in developing countries, needle anxiety in patients, and alternative drug delivery methods), opportunities (increasing research and development activities and strategic partnerships, increasing healthcare expenditure on diabetes care, advances in syringe and needle technology, and mandates pertaining to safety-engineered medical needles), challenges (needlestick injuries and misuse of injection pens and lack of interoperability among insulin delivery devices)
- Market Penetration: Complete knowledge of the spectrum of products presented by the major companies in the insulin delivery devices market
- Product Development/Innovation: Comprehensive understanding of the forthcoming trends, research and development initiatives, and product launches within the insulin delivery devices market
- Market Development: Complete knowledge about profitable developing regions
- Market Diversification: Exhaustive knowledge of new goods, expanding geographies, and current changes in the insulin delivery devices industry helps to diversify the market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players like Embecta Corp. (US), Novo Nordisk A/S (Denmark), Ypsomed (Switzerland), Medtronic (Ireland), Tandem Diabetes Care, Inc. (US), Sanofi (France), and Eli Lilly and Company (US)
Table of Contents
1 INTRODUCTION 33
1.1 STUDY OBJECTIVES 33
1.2 MARKET DEFINITION 33
1.3 MARKET SCOPE 34
1.3.1 STUDY INCLUSIONS AND EXCLUSIONS 34
1.3.2 MARKETS COVERED 35
1.3.3 YEARS CONSIDERED FOR STUDY 36
1.4 CURRENCY CONSIDERED 36
1.5 STAKEHOLDERS 37
1.6 SUMMARY OF CHANGES 37
2 RESEARCH METHODOLOGY 39
2.1 RESEARCH DATA 39
2.1.1 SECONDARY DATA 39
2.1.1.1 Key data from secondary sources 41
2.1.2 PRIMARY DATA 41
2.1.2.1 Key data from primary sources 43
2.1.2.2 Key industry insights 43
2.2 MARKET SIZE ESTIMATION 45
2.3 DATA TRIANGULATION 49
2.4 MARKET SHARE ESTIMATION 49
2.5 ASSUMPTIONS FOR STUDY 50
2.6 RESEARCH LIMITATIONS 50
2.6.1 SCOPE-RELATED LIMITATIONS 50
2.6.2 METHODOLOGY-RELATED LIMITATIONS 50
2.7 RISK ASSESSMENT 51
3 EXECUTIVE SUMMARY 52
4 PREMIUM INSIGHTS 56
4.1 INSULIN DELIVERY DEVICES: MARKET OVERVIEW 56
4.2 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE AND COUNTRY 57
4.3 INSULIN DELIVERY DEVICES MARKET: GEOGRAPHICAL MIX 58
4.4 INSULIN DELIVERY DEVICES MARKET: REGIONAL MIX 58
4.5 INSULIN DELIVERY DEVICES MARKET: DEVELOPED VS. DEVELOPING MARKETS 59
5 MARKET OVERVIEW 60
5.1 INTRODUCTION 60
5.2 MARKET DYNAMICS 60
5.2.1 DRIVERS 61
5.2.1.1 Growth in prevalence of diabetic population 61
5.2.1.2 Technological advancements in insulin delivery devices 62
5.2.1.3 Government support and favorable reimbursement schemes to favor the market growth 64
5.2.2 RESTRAINTS 64
5.2.2.1 High cost and lack of reimbursement in emerging economies 64
5.2.2.2 Needle anxiety in patients to affect growth of pen needles and syringes market 65
5.2.2.3 Oral insulin as alternative drug delivery method 65
5.2.3 OPPORTUNITIES 66
5.2.3.1 Increase in research & development activities and strategic partnerships 66
5.2.3.2 Increase in healthcare expenditure on diabetes care 67
5.2.3.3 Advances in insulin syringe and needle technology 67
5.2.3.4 Mandates pertaining to safety-engineered medical needles 68
5.2.4 CHALLENGES 68
5.2.4.1 Needlestick injuries and misuse of injection pens 68
5.2.4.2 Lack of interoperability among insulin delivery devices 69
5.3 REGULATORY ANALYSIS 70
5.3.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 70
5.3.2 REGULATORY FRAMEWORK 72
5.3.2.1 North America 72
5.3.2.1.1 US 72
5.3.2.1.2 Canada 73
5.3.2.2 Europe 74
5.3.2.3 Asia Pacific 76
5.3.2.3.1 Japan 76
5.3.2.3.2 China 76
5.3.2.3.3 India 77
5.3.2.3.4 Australia 77
5.3.2.4 Latin America 78
5.3.2.4.1 Brazil 79
5.3.2.4.2 Mexico 79
5.3.2.5 Middle East 79
5.3.2.6 Africa 79
5.4 INDUSTRY TRENDS 80
5.4.1 GROWING DEMAND FOR HYBRID CLOSED-LOOP SYSTEMS/ARTIFICIAL PANCREAS DEVICE SYSTEMS 80
5.4.2 SYNCHRONIZATION OF SMART INSULIN PENS WITH CONTINUOUS GLUCOSE MONITORING SYSTEMS PROMOTES DIABETES DATA SHARING 81
5.4.3 INCREASE IN NUMBER OF COLLABORATIONS AMONG STAKEHOLDERS 82
5.5 REIMBURSEMENT SCENARIO 82
5.5.1 GLOBAL COVERAGE AND REIMBURSEMENT 82
5.6 TECHNOLOGY ANALYSIS 84
5.7 TECHNOLOGY ANALYSIS 85
5.7.1 KEY TECHNOLOGIES 85
5.7.1.1 Automated insulin delivery 85
5.7.2 COMPLEMENTARY TECHNOLOGIES 85
5.7.2.1 Bluetooth 85
5.7.3 ADJACENT TECHNOLOGIES 86
5.7.3.1 Continuous glucose monitoring 86
5.8 KEY CONFERENCES & EVENTS 86
5.9 PRICING ANALYSIS 87
5.9.1 INDICATIVE PRICING TREND OF INSULIN DELIVERY DEVICE, BY KEY PLAYER 88
5.9.2 INDICATIVE PRICING TREND OF INSULIN DELIVERY DEVICE, BY REGION 88
5.10 TRADE ANALYSIS 89
5.11 PATENT ANALYSIS 90
5.11.1 PATENT PUBLICATION TRENDS FOR INSULIN DELIVERY DEVICES 90
5.11.2 JURISDICTION ANALYSIS: TOP APPLICANTS FOR PATENTS IN INSULIN DELIVERY DEVICES MARKET 90
5.12 SUPPLY CHAIN ANALYSIS 93
5.13 VALUE CHAIN ANALYSIS 94
5.14 ECOSYSTEM MARKET MAP 95
5.15 CASE STUDY ANALYSIS 96
5.15.1 OMNIPOD 5 FACILITATED EFFECTIVE INSULIN MANAGEMENT FOR YOUNG ATHLETES, SUPPORTING CONTINUITY IN TRAINING AND COMPETITION 96
5.15.2 MEDTRONIC MINIMED INSULIN PUMP ENHANCED GLUCOSE CONTROL, IMPROVING DAILY MANAGEMENT FOR PEOPLE WITH DIABETES 97
5.15.3 SMART INSULIN DELIVERY WITH MEDTRONIC INPEN FOR IMPROVED DIABETES MANAGEMENT 98
5.16 PORTER’S FIVE FORCES ANALYSIS 98
5.16.1 INTENSITY OF COMPETITIVE RIVALRY 99
5.16.2 BARGAINING POWER OF SUPPLIERS 99
5.16.3 BARGAINING POWER OF BUYERS 99
5.16.4 THREAT OF SUBSTITUTES 100
5.16.5 THREAT OF NEW ENTRANTS 100
5.17 KEY STAKEHOLDERS AND BUYING CRITERIA 100
5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS 100
5.17.2 BUYING CRITERIA 101
5.18 ADJACENT MARKET ANALYSIS 102
5.19 INVESTMENT & FUNDING SCENARIO 102
5.20 UNMET NEEDS/END-USER EXPECTATIONS IN INSULIN DELIVERY DEVICES MARKET 102
5.21 TRENDS/DISRUPTION IMPACTING CUSTOMER’S BUSINESS 104
5.22 IMPACT OF AI/GENERATIVE AI ON INSULIN DELIVERY DEVICES MARKET 104
6 INSULIN DELIVERY DEVICES MARKET, BY TYPE 106
6.1 INTRODUCTION 107
6.2 INSULIN PENS 108
6.2.1 ADVANCED AND CONVENIENT SOLUTIONS FOR INSULIN ADMINISTRATION TO DRIVE MARKET 108
6.2.2 REUSABLE INSULIN PENS 109
6.2.2.1 Technology innovations offering cost-effectiveness to boost growth 109
6.2.3 DISPOSABLE INSULIN PENS 111
6.2.3.1 Ease of use to drive market, though shift toward eco-friendly environment can challenge growth 111
6.3 INSULIN PUMPS 113
6.3.1 PRECISION OFFERED BY NEWER AND MORE REFINED TECHNOLOGY TO DRIVE INSULIN PUMPS MARKET 113
6.3.2 TETHERED INSULIN PUMPS 115
6.3.2.1 Increase in collaborations and partnerships between companies to develop integrated CGM systems to drive market 115
6.3.3 TUBELESS INSULIN PUMPS 116
6.3.3.1 Use of artificial intelligence and technological advancements to boost market 116
6.4 INSULIN PEN NEEDLES 118
6.4.1 STANDARD INSULIN PEN NEEDLES 119
6.4.1.1 Affordability of standard insulin pen needles over safety pen needles to propel growth 119
6.4.2 SAFETY INSULIN PEN NEEDLES 123
6.4.2.1 Reduced chances of infection and accidental pricking to drive market 123
6.5 INSULIN SYRINGES 125
6.5.1 COMMONLY USED DELIVERY MEANS CHALLENGED BY SAFETY CONCERNS AND AWARENESS OF AFFORDABLE ALTERNATIVES 125
6.6 OTHER INSULIN DELIVERY DEVICES 127
7 INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE 130
7.1 INTRODUCTION 131
7.2 TYPE 1 DIABETES 131
7.2.1 CHRONIC NATURE OF TYPE 1 DIABETES, COMBINED WITH SIGNIFICANT INCIDENCE IN CHILDREN AND YOUNG ADULTS, TO DRIVE GROWTH 131
7.3 TYPE 2 DIABETES 134
7.3.1 RISING PREVALENCE OF TYPE 2 DIABETES, DRIVEN BY LIFESTYLE-RELATED RISK FACTORS AND EARLIER DISEASE ONSET TO FUEL MARKET 134
8 INSULIN DELIVERY DEVICES MARKET, BY END USER 137
8.1 INTRODUCTION 138
8.2 HOME CARE SETTINGS 139
8.2.1 INCREASE IN AFFORDABILITY OF SELF-MONITORING SYSTEMS AND INSULIN DELIVERY DEVICES TO FUEL SELF/HOME HEALTHCARE 139
8.3 HOSPITALS & CLINICS 141
8.3.1 RISE IN DEMAND FOR POINT-OF-CARE TESTING IN HOSPITALS TO BOOST MARKET GROWTH 141
8.4 OTHER END USERS 144
9 INSULIN DELIVERY DEVICES MARKET, BY REGION 146
9.1 INTRODUCTION 147
9.2 NORTH AMERICA 148
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 149
9.2.2 US 154
9.2.2.1 Largest share of North American insulin delivery device market 154
9.2.3 CANADA 159
9.2.3.1 Rise in government support to boost market in Canada 159
9.3 EUROPE 165
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 165
9.3.2 GERMANY 170
9.3.2.1 Germany to dominate European insulin delivery devices market 170
9.3.3 UK 175
9.3.3.1 Government support and research funding to drive market growth in UK 175
9.3.4 FRANCE 179
9.3.4.1 High insurance coverage and increasing affordability to fuel market 179
9.3.5 ITALY 183
9.3.5.1 Increase in government spending to drive insulin delivery device growth in Italy 183
9.3.6 SPAIN 188
9.3.6.1 Minimal co-payments and full reimbursement to drive market growth in Spain 188
9.3.7 REST OF EUROPE (ROE) 192
9.4 ASIA PACIFIC 196
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 196
9.4.2 CHINA 203
9.4.2.1 China to dominate Asia Pacific’s insulin delivery devices market 203
9.4.3 JAPAN 207
9.4.3.1 Rise in aging population and high diabetes cases to drive growth in Japan 207
9.4.4 INDIA 212
9.4.4.1 Rise in diabetes cases and affordable local manufacturing to fuel insulin device demand in India 212
9.4.5 AUSTRALIA 216
9.4.5.1 Government subsidies to support market growth 216
9.4.6 SOUTH KOREA 221
9.4.6.1 Rise in diabetes cases and strong government healthcare support to boost market 221
9.4.7 REST OF ASIA PACIFIC 225
9.5 LATIN AMERICA 229
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 229
9.5.2 BRAZIL 234
9.5.2.1 Brazil to account for largest share in Latin American insulin delivery devices market 234
9.5.3 MEXICO 239
9.5.3.1 Growth in regulatory support to propel market 239
9.5.4 REST OF LATIN AMERICA 243
9.6 MIDDLE EAST & AFRICA 247
9.6.1 MACROECONOMIC OUTLOOK FOR THE MIDDLE EAST & AFRICA 247
9.6.2 GCC COUNTRIES 252
9.6.2.1 Rise in diabetes prevalence and high per capita healthcare expenditure to drive market in GCC countries 252
9.6.3 REST OF THE MIDDLE EAST & AFRICA 257
10 COMPETITIVE LANDSCAPE 262
10.1 INTRODUCTION 262
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 262
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN INSULIN DELIVERY DEVICES MARKET 262
10.3 REVENUE ANALYSIS, 2022–2024 264
10.4 MARKET SHARE ANALYSIS, 2024 264
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 266
10.5.1 STARS 267
10.5.2 EMERGING LEADERS 267
10.5.3 PERVASIVE PLAYERS 267
10.5.4 PARTICIPANTS 267
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 269
10.5.5.1 Company footprint 269
10.5.5.2 Type footprint 270
10.5.5.3 Region footprint 271
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 272
10.6.1 PROGRESSIVE COMPANIES 272
10.6.2 RESPONSIVE COMPANIES 272
10.6.3 DYNAMIC COMPANIES 272
10.6.4 STARTING BLOCKS 272
10.6.5 COMPETITIVE BENCHMARKING 274
10.6.5.1 DETAILED LIST OF KEY STARTUPS/SMES, 2024 274
10.6.5.2 COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 275
10.7 BRAND/PRODUCT COMPARISON 276
10.8 COMPANY VALUATION & FINANCIAL METRICS 277
10.8.1 FINANCIAL METRICS 277
10.8.2 COMPANY VALUATION 277
10.9 R&D ASSESSMENT OF KEY PLAYERS 278
10.10 COMPETITIVE SCENARIO 278
10.10.1 PRODUCT LAUNCHES & APPROVALS 278
10.10.2 DEALS 285
10.10.3 EXPANSIONS 291
10.10.4 OTHER DEVELOPMENTS 294
11 COMPANY PROFILES 296
11.1 KEY PLAYERS 296
11.1.1 EMBECTA CORP. (FORMERLY BECTON, DICKINSON AND COMPANY DIABETES CARE BUSINESS) 296
11.1.1.1 Business overview 296
11.1.1.2 Products offered 297
11.1.1.3 Recent developments 298
11.1.1.3.1 Product launches and approvals 298
11.1.1.3.2 Deals 298
11.1.1.3.3 Expansions 299
11.1.1.3.4 Other developments 299
11.1.1.4 MnM view 299
11.1.1.4.1 Right to win 299
11.1.1.4.2 Strategic choices 300
11.1.1.4.3 Weaknesses & competitive threats 300
11.1.2 NOVO NORDISK A/S 301
11.1.2.1 Business overview 301
11.1.2.2 Products offered 302
11.1.2.3 Recent developments 303
11.1.2.3.1 Product launches and approvals 303
11.1.2.3.2 Deals 303
11.1.2.3.3 Other developments 305
11.1.2.4 MnM view 306
11.1.2.4.1 Right to win 306
11.1.2.4.2 Strategic choices 306
11.1.2.4.3 Weaknesses & competitive threats 306
11.1.3 MEDTRONIC 307
11.1.3.1 Business overview 307
11.1.3.2 Products offered 308
11.1.3.3 Recent developments 309
11.1.3.3.1 Product launches and approvals 309
11.1.3.3.2 Deals 310
11.1.3.3.3 Expansions 311
11.1.3.3.4 Other developments 311
11.1.3.4 MnM view 311
11.1.3.4.1 Right to win 311
11.1.3.4.2 Strategic choices 312
11.1.3.4.3 Weaknesses & competitive threats 312
11.1.4 SANOFI 313
11.1.4.1 Business overview 313
11.1.4.2 Products offered 314
11.1.4.3 Recent developments 315
11.1.4.3.1 Product launches and approvals 315
11.1.4.3.2 Expansions 315
11.1.4.3.3 Other developments 316
11.1.4.4 MnM view 316
11.1.4.4.1 Right to win 316
11.1.4.4.2 Strategic choices 316
11.1.4.4.3 Weaknesses & competitive threats 317
11.1.5 ELI LILLY AND COMPANY 318
11.1.5.1 Business overview 318
11.1.5.2 Products offered 319
11.1.5.3 Recent developments 320
11.1.5.3.1 Product launches and approvals 320
11.1.5.3.2 Deals 320
11.1.5.3.3 Expansions 321
11.1.5.3.4 Other developments 321
11.1.5.4 MnM view 322
11.1.5.4.1 Right to win 322
11.1.5.4.2 Strategic choices 322
11.1.5.4.3 Weaknesses and competitive threats 322
11.1.6 TANDEM DIABETES CARE, INC. 323
11.1.6.1 Business overview 323
11.1.6.2 Products offered 324
11.1.6.3 Recent developments 325
11.1.6.3.1 Product launches and approvals 325
11.1.6.3.2 Deals 326
11.1.7 INSULET CORPORATION 328
11.1.7.1 Business overview 328
11.1.7.2 Products offered 329
11.1.7.3 Recent developments 330
11.1.7.3.1 Product launches and approvals 330
11.1.7.3.2 Deals 332
11.1.7.3.3 Expansions 332
11.1.7.3.4 Other developments 333
11.1.8 BIOCON 334
11.1.8.1 Business overview 334
11.1.8.2 Products offered 335
11.1.8.3 Recent developments 336
11.1.8.3.1 Deals 336
11.1.8.3.2 Other developments 337
11.1.9 ROCHE DIABETES CARE 338
11.1.9.1 Business overview 338
11.1.9.2 Products offered 339
11.1.9.3 Recent developments 340
11.1.9.3.1 Product launches and approvals 340
11.1.10 HTL-STREFA (SUBSIDIARY OF THE MTD GROUP) 341
11.1.10.1 Business overview 341
11.1.10.2 Products offered 342
11.1.10.3 Recent developments 342
11.1.10.3.1 Deals 342
11.1.11 YPSOMED 343
11.1.11.1 Business overview 343
11.1.11.2 Products offered 344
11.1.11.3 Recent developments 345
11.1.11.3.1 Product launches and approvals 345
11.1.11.3.2 Deals 346
11.1.11.3.3 Expansions 347
11.1.11.3.4 Other developments 348
11.1.12 MEDTRUM TECHNOLOGIES INC. 349
11.1.12.1 Business overview 349
11.1.12.2 Products offered 349
11.1.13 TERUMO CORPORATION 350
11.1.13.1 Business overview 350
11.1.13.2 Products offered 351
11.1.13.3 Recent developments 352
11.1.13.3.1 Product launches and approvals 352
11.1.13.3.2 Deals 352
11.1.13.3.3 Expansions 353
11.1.13.3.4 Other developments 353
11.1.14 WOCKHARDT LIMITED 354
11.1.14.1 Business overview 354
11.1.14.2 Products offered 355
11.1.14.3 Recent developments 355
11.1.14.3.1 Product launches and approvals 355
11.1.14.3.2 Other developments 356
11.1.15 NIPRO 357
11.1.15.1 Business overview 357
11.1.15.2 Products offered 358
11.1.15.3 Recent developments 359
11.1.15.3.1 Expansions 359
11.2 OTHER PLAYERS 360
11.2.1 CEQUR CORPORATION 360
11.2.2 EOFLOW CO., LTD. 361
11.2.3 HINDUSTAN SYRINGES & MEDICAL DEVICES LTD 362
11.2.4 SOOIL DEVELOPMENTS CO., LTD 363
11.2.5 SUNGSHIM MEDICAL CO., LTD. 364
11.2.6 B.BRAUN SE 365
11.2.7 DEBIOTECH SA 366
11.2.8 JIANGSU DELFU MEDICAL DEVICE CO., LTD 367
11.2.9 HASELMEIER (A SUBSIDIARY OF MEDMIX) 368
11.2.10 MANNKIND CORPORATION 369
12 APPENDIX 370
12.1 DISCUSSION GUIDE 370
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 375
12.3 CUSTOMIZATION OPTIONS 377
12.4 RELATED REPORTS 377
12.5 AUTHOR DETAILS 378
LIST OF TABLES
TABLE 1 INCLUSION AND EXCLUSIONS 34
TABLE 2 STANDARD CURRENCY CONVERSION RATES (USD) 36
TABLE 3 RISK ASSESSMENT: INSULIN DELIVERY DEVICES MARKET 51
TABLE 4 TOP 10 COUNTRIES/TERRITORIES WITH HIGHEST NUMBER OF ADULTS (20–79 YEARS) WITH DIABETES, 2024 AND 2050 (MILLION) 62
TABLE 5 TOTAL DIABETES-RELATED HEALTH EXPENDITURE ACROSS REGIONS,
2024 AND 2050 (USD MILLION) 67
TABLE 6 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 70
TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 70
TABLE 8 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 71
TABLE 9 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 71
TABLE 10 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 72
TABLE 11 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 72
TABLE 12 EUROPE: MEDICAL DEVICES, BY CLASS 74
TABLE 13 EUROPE: CONFORMITY ASSESSMENT 75
TABLE 14 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODY 76
TABLE 15 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 76
TABLE 16 INDIA: MEDICAL DEVICE CLASSIFICATION 77
TABLE 17 HYBRID CLOSED-LOOP SYSTEMS: CURRENT MARKET SCENARIO 80
TABLE 18 MAJOR SMART INSULIN PENS AVAILABLE GLOBALLY 81
TABLE 19 RECENT COLLABORATIONS IN INSULIN DELIVERY DEVICE MARKET 82
TABLE 20 US: INSULIN DELIVERY DEVICE COVERAGE AND REIMBURSEMENT 82
TABLE 21 CANADA: INSULIN DELIVERY DEVICE COVERAGE AND REIMBURSEMENT 83
TABLE 22 UK: INSULIN DELIVERY DEVICE COVERAGE AND REIMBURSEMENT 83
TABLE 23 AUSTRALIA: INSULIN DELIVERY DEVICES COVERAGE AND REIMBURSEMENT 84
TABLE 24 OTHER COUNTRIES: INSULIN DELIVERY DEVICE COVERAGE AND REIMBURSEMENT 84
TABLE 25 INSULIN DELIVERY DEVICES MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2025–2026 86
TABLE 26 INDICATIVE PRICING TREND OF INSULIN DELIVERY DEVICE, BY KEY PLAYER, 2022–2024 (USD) 88
TABLE 27 INDICATIVE PRICING TREND OF INSULIN DELIVERY DEVICE, BY REGION,
2022–2024 (USD) 88
TABLE 28 IMPORT DATA FOR INSULIN DELIVERY SYSTEMS (HS CODE: 901839),
BY COUNTRY, 2020–2023 (USD THOUSAND) 89
TABLE 29 EXPORT DATA FOR INSULIN DELIVERY SYSTEMS (HS CODE: 901839),
BY COUNTRY, 2020–2023 (USD THOUSAND) 89
TABLE 30 LIST OF PATENTS IN INSULIN DELIVERY DEVICES MARKET, 2022−2024 92
TABLE 31 INSULIN DELIVERY DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 99
TABLE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF END USERS 101
TABLE 33 KEY BUYING CRITERIA FOR END USERS 101
TABLE 34 UNMET NEEDS: INSULIN DELIVERY DEVICES MARKET 102
TABLE 35 END-USER EXPECTATIONS: INSULIN DELIVERY DEVICES MARKET 103
TABLE 36 INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION) 107
TABLE 37 INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION) 107
TABLE 38 INSULIN PENS MARKET, BY TYPE, 2022–2024 (USD MILLION) 108
TABLE 39 INSULIN PENS MARKET, BY TYPE, 2025–2030 (USD MILLION) 108
TABLE 40 REUSABLE INSULIN PENS MARKET, BY COUNTRY, 2022–2024 (USD MILLION) 110
TABLE 41 REUSABLE INSULIN PENS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 111
TABLE 42 DISPOSABLE INSULIN PENS MARKET, BY COUNTRY, 2022–2024 (USD MILLION) 112
TABLE 43 DISPOSABLE INSULIN PENS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 113
TABLE 44 INSULIN PUMPS MARKET, BY TYPE, 2022–2024 (USD MILLION) 114
TABLE 45 INSULIN PUMPS MARKET, BY TYPE, 2025–2030 (USD MILLION) 114
TABLE 46 TETHERED INSULIN PUMPS MARKET, BY COUNTRY, 2022–2024 (USD MILLION) 115
TABLE 47 TETHERED INSULIN PUMPS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 116
TABLE 48 TUBELESS INSULIN PUMPS MARKET, BY COUNTRY, 2022–2024 (USD MILLION) 117
TABLE 49 TUBELESS INSULIN PUMPS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 118
TABLE 50 INSULIN PEN NEEDLES MARKET, BY TYPE, 2022–2024 (USD MILLION) 119
TABLE 51 INSULIN PEN NEEDLES MARKET, BY TYPE, 2025–2030 (USD MILLION) 119
TABLE 52 STANDARD INSULIN PEN NEEDLES OFFERED BY KEY PLAYERS 120
TABLE 53 STANDARD INSULIN PEN NEEDLES MARKET, BY COUNTRY,
2022–2024 (USD MILLION) 121
TABLE 54 STANDARD INSULIN PEN NEEDLES MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 122
TABLE 55 SAFETY INSULIN PEN NEEDLES OFFERED BY KEY PLAYERS 123
TABLE 56 SAFETY INSULIN PEN NEEDLES MARKET, BY COUNTRY,
2022–2024 (USD MILLION) 124
TABLE 57 SAFETY INSULIN PEN NEEDLES MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 125
TABLE 58 INSULIN SYRINGES MARKET, BY COUNTRY, 2022–2024 (USD MILLION) 126
TABLE 59 INSULIN SYRINGES MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 127
TABLE 60 OTHER INSULIN DELIVERY DEVICES MARKET, BY COUNTRY,
2022–2024 (USD MILLION) 128
TABLE 61 OTHER INSULIN DELIVERY DEVICES MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 129
TABLE 62 INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2022–2024 (USD MILLION) 131
TABLE 63 INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2025–2030 (USD MILLION) 131
TABLE 64 INSULIN DELIVERY DEVICES MARKET FOR TYPE 1 DIABETES,
BY COUNTRY, 2022–2024 (USD MILLION) 132
TABLE 65 INSULIN DELIVERY DEVICES MARKET FOR TYPE 1 DIABETES,
BY COUNTRY, 2025–2030 (USD MILLION) 133
TABLE 66 INSULIN DELIVERY DEVICES MARKET FOR TYPE 2 DIABETES,
BY COUNTRY, 2022–2024 (USD MILLION) 135
TABLE 67 INSULIN DELIVERY DEVICES MARKET FOR TYPE 2 DIABETES,
BY COUNTRY, 2025–2030 (USD MILLION) 136
TABLE 68 INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION) 138
TABLE 69 INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION) 138
TABLE 70 INSULIN DELIVERY DEVICES MARKET FOR HOME CARE SETTINGS, BY REGION, 2022–2024 (USD MILLION) 140
TABLE 71 INSULIN DELIVERY DEVICES MARKET FOR HOME CARE SETTINGS, BY REGION, 2025–2030 (USD MILLION) 141
TABLE 72 INSULIN DELIVERY DEVICES MARKET FOR HOSPITALS & CLINICS, BY REGION, 2022–2024 (USD MILLION) 142
TABLE 73 INSULIN DELIVERY DEVICES MARKET FOR HOSPITALS & CLINICS, BY REGION, 2025–2030 (USD MILLION) 143
TABLE 74 INSULIN DELIVERY DEVICES MARKET FOR OTHER END USERS, BY REGION,
2022–2024 (USD MILLION) 144
TABLE 75 INSULIN DELIVERY DEVICES MARKET FOR OTHER END USERS, BY REGION,
2025–2030 (USD MILLION) 145
TABLE 76 INSULIN DELIVERY DEVICES MARKET, BY REGION, 2022–2024 (USD MILLION) 148
TABLE 77 INSULIN DELIVERY DEVICES MARKET, BY REGION, 2025–2030 (USD MILLION) 148
TABLE 78 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY,
2022–2024 (USD MILLION) 150
TABLE 79 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 150
TABLE 80 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE,
2022–2024 (USD MILLION) 150
TABLE 81 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE,
2025–2030 (USD MILLION) 151
TABLE 82 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS,
BY TYPE, 2022–2024 (USD MILLION) 151
TABLE 83 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS,
BY TYPE, 2025–2030 (USD MILLION) 151
TABLE 84 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS,
BY TYPE, 2022–2024 (USD MILLION) 152
TABLE 85 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS,
BY TYPE, 2025–2030 (USD MILLION) 152
TABLE 86 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 152
TABLE 87 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 153
TABLE 88 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2022–2024 (USD MILLION) 153
TABLE 89 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2025–2030 (USD MILLION) 153
TABLE 90 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2022–2024 (USD MILLION) 154
TABLE 91 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2025–2030 (USD MILLION) 154
TABLE 92 US: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION) 155
TABLE 93 US: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION) 155
TABLE 94 US: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE,
2022–2024 (USD MILLION) 155
TABLE 95 US: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE,
2025–2030 (USD MILLION) 156
TABLE 96 US: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE,
2022–2024 (USD MILLION) 156
TABLE 97 US: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE,
2025–2030 (USD MILLION) 156
TABLE 98 US: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 157
TABLE 99 US: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 157
TABLE 100 US: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2022–2024 (USD MILLION) 157
TABLE 101 US: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2025–2030 (USD MILLION) 158
TABLE 102 US: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2022–2024 (USD MILLION) 158
TABLE 103 US: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2025–2030 (USD MILLION) 158
TABLE 104 ELIGIBILITY FOR INSULIN PUMPS AND SUPPLIES IN CANADA FOR
TYPE I DIABETES, 2023 159
TABLE 105 CANADA: INSULIN DELIVERY DEVICES MARKET, BY TYPE,
2022–2024 (USD MILLION) 161
TABLE 106 CANADA: INSULIN DELIVERY DEVICES MARKET, BY TYPE,
2025–2030 (USD MILLION) 161
TABLE 107 CANADA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION) 161
TABLE 108 CANADA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION) 162
TABLE 109 CANADA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 162
TABLE 110 CANADA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 162
TABLE 111 CANADA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES,
BY TYPE, 2022–2024 (USD MILLION) 163
TABLE 112 CANADA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES,
BY TYPE, 2025–2030 (USD MILLION) 163
TABLE 113 CANADA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2022–2024 (USD MILLION) 163
TABLE 114 CANADA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2025–2030 (USD MILLION) 164
TABLE 115 CANADA: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2022–2024 (USD MILLION) 164
TABLE 116 CANADA: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2025–2030 (USD MILLION) 164
TABLE 117 EUROPE: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY,
2022–2024 (USD MILLION) 165
TABLE 118 EUROPE: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 166
TABLE 119 EUROPE: INSULIN DELIVERY DEVICES MARKET, BY TYPE,
2022–2024 (USD MILLION) 166
TABLE 120 EUROPE: INSULIN DELIVERY DEVICES MARKET, BY TYPE,
2025–2030 (USD MILLION) 167
TABLE 121 EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION) 167
TABLE 122 EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION) 167
TABLE 123 EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 168
TABLE 124 EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 168
TABLE 125 EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES,
BY TYPE, 2022–2024 (USD MILLION) 168
TABLE 126 EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES,
BY TYPE, 2025–2030 (USD MILLION) 169
TABLE 127 EUROPE: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2022–2024 (USD MILLION) 169
TABLE 128 EUROPE: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2025–2030 (USD MILLION) 169
TABLE 129 EUROPE: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2022–2024 (USD MILLION) 170
TABLE 130 EUROPE: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2025–2030 (USD MILLION) 170
TABLE 131 GERMANY: INSULIN DELIVERY DEVICES MARKET, BY TYPE,
2022–2024 (USD MILLION) 171
TABLE 132 GERMANY: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION) 171
TABLE 133 GERMANY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION) 171
TABLE 134 GERMANY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION) 172
TABLE 135 GERMANY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 172
TABLE 136 GERMANY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 172
TABLE 137 GERMANY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES,
BY TYPE, 2022–2024 (USD MILLION) 173
TABLE 138 GERMANY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES,
BY TYPE, 2025–2030 (USD MILLION) 173
TABLE 139 GERMANY: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2022–2024 (USD MILLION) 173
TABLE 140 GERMANY: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2025–2030 (USD MILLION) 174
TABLE 141 GERMANY: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2022–2024 (USD MILLION) 174
TABLE 142 GERMANY: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2025–2030 (USD MILLION) 174
TABLE 143 UK: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION) 175
TABLE 144 UK: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION) 175
TABLE 145 UK: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE,
2022–2024 (USD MILLION) 176
TABLE 146 UK: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE,
2025–2030 (USD MILLION) 176
TABLE 147 UK: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE,
2022–2024 (USD MILLION) 176
TABLE 148 UK: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE,
2025–2030 (USD MILLION) 177
TABLE 149 UK: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 177
TABLE 150 UK: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 177
TABLE 151 UK: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2022–2024 (USD MILLION) 178
TABLE 152 UK: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2025–2030 (USD MILLION) 178
TABLE 153 UK: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2022–2024 (USD MILLION) 178
TABLE 154 UK: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2025–2030 (USD MILLION) 179
TABLE 155 FRANCE: INSULIN DELIVERY DEVICES MARKET, BY TYPE,
2022–2024 (USD MILLION) 179
TABLE 156 FRANCE: INSULIN DELIVERY DEVICES MARKET, BY TYPE,
2025–2030 (USD MILLION) 180
TABLE 157 FRANCE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION) 180
TABLE 158 FRANCE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION) 180
TABLE 159 FRANCE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 181
TABLE 160 FRANCE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 181
TABLE 161 FRANCE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES,
BY TYPE, 2022–2024 (USD MILLION) 181
TABLE 162 FRANCE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES,
BY TYPE, 2025–2030 (USD MILLION) 182
TABLE 163 FRANCE: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2022–2024 (USD MILLION) 182
TABLE 164 FRANCE: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2025–2030 (USD MILLION) 182
TABLE 165 FRANCE: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2022–2024 (USD MILLION) 183
TABLE 166 FRANCE: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2025–2030 (USD MILLION) 183
TABLE 167 ITALY: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION) 184
TABLE 168 ITALY: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION) 184
TABLE 169 ITALY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE,
2022–2024 (USD MILLION) 184
TABLE 170 ITALY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE,
2025–2030 (USD MILLION) 185
TABLE 171 ITALY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE,
2022–2024 (USD MILLION) 185
TABLE 172 ITALY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE,
2025–2030 (USD MILLION) 185
TABLE 173 ITALY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES,
BY TYPE, 2022–2024 (USD MILLION) 186
TABLE 174 ITALY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 186
TABLE 175 ITALY: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2022–2024 (USD MILLION) 186
TABLE 176 ITALY: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2025–2030 (USD MILLION) 187
TABLE 177 ITALY: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2022–2024 (USD MILLION) 187
TABLE 178 ITALY: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2025–2030 (USD MILLION) 187
TABLE 179 SPAIN: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION) 188
TABLE 180 SPAIN: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION) 188
TABLE 181 SPAIN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE,
2022–2024 (USD MILLION) 189
TABLE 182 SPAIN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE,
2025–2030 (USD MILLION) 189
TABLE 183 SPAIN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 189
TABLE 184 SPAIN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 190
TABLE 185 SPAIN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 190
TABLE 186 SPAIN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 190
TABLE 187 SPAIN: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2022–2024 (USD MILLION) 191
TABLE 188 SPAIN: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2025–2030 (USD MILLION) 191
TABLE 189 SPAIN: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2022–2024 (USD MILLION) 191
TABLE 190 SPAIN: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2025–2030 (USD MILLION) 192
TABLE 191 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET, BY TYPE,
2022–2024 (USD MILLION) 192
TABLE 192 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET, BY TYPE,
2025–2030 (USD MILLION) 193
TABLE 193 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS,
BY TYPE, 2022–2024 (USD MILLION) 193
TABLE 194 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS,
BY TYPE, 2025–2030 (USD MILLION) 193
TABLE 195 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS,
BY TYPE, 2022–2024 (USD MILLION) 194
TABLE 196 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS,
BY TYPE, 2025–2030 (USD MILLION) 194
TABLE 197 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 194
TABLE 198 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 195
TABLE 199 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2022–2024 (USD MILLION) 195
TABLE 200 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2025–2030 (USD MILLION) 195
TABLE 201 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2022–2024 (USD MILLION) 196
TABLE 202 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2025–2030 (USD MILLION) 196
TABLE 203 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY,
2022–2024 (USD MILLION) 198
TABLE 204 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 198
TABLE 205 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY TYPE,
2022–2024 (USD MILLION) 199
TABLE 206 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY TYPE,
2025–2030 (USD MILLION) 199
TABLE 207 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION) 199
TABLE 208 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION) 200
TABLE 209 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 200
TABLE 210 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 200
TABLE 211 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 201
TABLE 212 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 201
TABLE 213 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2022–2024 (USD MILLION) 201
TABLE 214 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2025–2030 (USD MILLION) 202
TABLE 215 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2022–2024 (USD MILLION) 202
TABLE 216 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2025–2030 (USD MILLION) 202
TABLE 217 CHINA: INSULIN DELIVERY DEVICES MARKET, BY TYPE,
2022–2024 (USD MILLION) 203
TABLE 218 CHINA: INSULIN DELIVERY DEVICES MARKET, BY TYPE,
2025–2030 (USD MILLION) 204
TABLE 219 CHINA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE,
2022–2024 (USD MILLION) 204
TABLE 220 CHINA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE,
2025–2030 (USD MILLION) 204
TABLE 221 CHINA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 205
TABLE 222 CHINA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 205
TABLE 223 CHINA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES,
BY TYPE, 2022–2024 (USD MILLION) 205
TABLE 224 CHINA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES,
BY TYPE, 2025–2030 (USD MILLION) 206
TABLE 225 CHINA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2022–2024 (USD MILLION) 206
TABLE 226 CHINA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2025–2030 (USD MILLION) 206
TABLE 227 CHINA: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2022–2024 (USD MILLION) 207
TABLE 228 CHINA: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2025–2030 (USD MILLION) 207
TABLE 229 JAPAN: INSULIN DELIVERY DEVICES MARKET, BY TYPE,
2022–2024 (USD MILLION) 208
TABLE 230 JAPAN: INSULIN DELIVERY DEVICES MARKET, BY TYPE,
2025–2030 (USD MILLION) 208
TABLE 231 JAPAN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE,
2022–2024 (USD MILLION) 208
TABLE 232 JAPAN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE,
2025–2030 (USD MILLION) 209
TABLE 233 JAPAN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 209
TABLE 234 JAPAN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 209
TABLE 235 JAPAN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 210
TABLE 236 JAPAN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 210
TABLE 237 JAPAN: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2022–2024 (USD MILLION) 210
TABLE 238 JAPAN: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2025–2030 (USD MILLION) 211
TABLE 239 JAPAN: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2022–2024 (USD MILLION) 211
TABLE 240 JAPAN: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2025–2030 (USD MILLION) 211
TABLE 241 INDIA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION) 212
TABLE 242 INDIA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION) 213
TABLE 243 INDIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE,
2022–2024 (USD MILLION) 213
TABLE 244 INDIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE,
2025–2030 (USD MILLION) 213
TABLE 245 INDIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE,
2022–2024 (USD MILLION) 214
TABLE 246 INDIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE,
2025–2030 (USD MILLION) 214
TABLE 247 INDIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 214
TABLE 248 INDIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 215
TABLE 249 INDIA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2022–2024 (USD MILLION) 215
TABLE 250 INDIA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2025–2030 (USD MILLION) 215
TABLE 251 INDIA: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2022–2024 (USD MILLION) 216
TABLE 252 INDIA: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2025–2030 (USD MILLION) 216
TABLE 253 AUSTRALIA: INSULIN DELIVERY DEVICES MARKET, BY TYPE,
2022–2024 (USD MILLION) 217
TABLE 254 AUSTRALIA: INSULIN DELIVERY DEVICES MARKET, BY TYPE,
2025–2030 (USD MILLION) 217
TABLE 255 AUSTRALIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION) 217
TABLE 256 AUSTRALIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION) 218
TABLE 257 AUSTRALIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 218
TABLE 258 AUSTRALIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 218
TABLE 259 AUSTRALIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES,
BY TYPE, 2022–2024 (USD MILLION) 219
TABLE 260 AUSTRALIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES,
BY TYPE, 2025–2030 (USD MILLION) 219
TABLE 261 AUSTRALIA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2022–2024 (USD MILLION) 219
TABLE 262 AUSTRALIA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2025–2030 (USD MILLION) 220
TABLE 263 AUSTRALIA: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2022–2024 (USD MILLION) 220
TABLE 264 AUSTRALIA: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2025–2030 (USD MILLION) 220
TABLE 265 SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET, BY TYPE,
2022–2024 (USD MILLION) 221
TABLE 266 SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET, BY TYPE,
2025–2030 (USD MILLION) 221
TABLE 267 SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION) 222
TABLE 268 SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION) 222
TABLE 269 SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS,
BY TYPE, 2022–2024 (USD MILLION) 222
TABLE 270 SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS,
BY TYPE, 2025–2030 (USD MILLION) 223
TABLE 271 SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 223
TABLE 272 SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 223
TABLE 273 SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2022–2024 (USD MILLION) 224
TABLE 274 SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2025–2030 (USD MILLION) 224
TABLE 275 SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2022–2024 (USD MILLION) 224
TABLE 276 SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2025–2030 (USD MILLION) 225
TABLE 277 REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY TYPE,
2022–2024 (USD MILLION) 225
TABLE 278 REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY TYPE,
2025–2030 (USD MILLION) 226
TABLE 279 REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION) 226
TABLE 280 REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION) 226
TABLE 281 REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 227
TABLE 282 REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 227
TABLE 283 REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 227
TABLE 284 REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 228
TABLE 285 REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION) 228
TABLE 286 REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION) 228
TABLE 287 REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION) 229
TABLE 288 REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION) 229
TABLE 289 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY,
2022–2024 (USD MILLION) 230
TABLE 290 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 230
TABLE 291 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE,
2022–2024 (USD MILLION) 230
TABLE 292 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE,
2025–2030 (USD MILLION) 231
TABLE 293 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS,
BY TYPE, 2022–2024 (USD MILLION) 231
TABLE 294 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS,
BY TYPE, 2025–2030 (USD MILLION) 231
TABLE 295 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS,
BY TYPE, 2022–2024 (USD MILLION) 232
TABLE 296 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS,
BY TYPE, 2025–2030 (USD MILLION) 232
TABLE 297 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 232
TABLE 298 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 233
TABLE 299 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2022–2024 (USD MILLION) 233
TABLE 300 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2025–2030 (USD MILLION) 233
TABLE 301 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2022–2024 (USD MILLION) 234
TABLE 302 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2025–2030 (USD MILLION) 234
TABLE 303 BRAZIL: INSULIN DELIVERY DEVICES MARKET, BY TYPE,
2022–2024 (USD MILLION) 235
TABLE 304 BRAZIL: INSULIN DELIVERY DEVICES MARKET, BY TYPE,
2025–2030 (USD MILLION) 235
TABLE 305 BRAZIL: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE,
2022–2024 (USD MILLION) 235
TABLE 306 BRAZIL: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE,
2025–2030 (USD MILLION) 236
TABLE 307 BRAZIL: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 236
TABLE 308 BRAZIL: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 236
TABLE 309 BRAZIL: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES,
BY TYPE, 2022–2024 (USD MILLION) 237
TABLE 310 BRAZIL: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES,
BY TYPE, 2025–2030 (USD MILLION) 237
TABLE 311 BRAZIL: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2022–2024 (USD MILLION) 237
TABLE 312 BRAZIL: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2025–2030 (USD MILLION) 238
TABLE 313 BRAZIL: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2022–2024 (USD MILLION) 238
TABLE 314 BRAZIL: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2025–2030 (USD MILLION) 238
TABLE 315 MEXICO: INSULIN DELIVERY DEVICES MARKET, BY TYPE,
2022–2024 (USD MILLION) 239
TABLE 316 MEXICO: INSULIN DELIVERY DEVICES MARKET, BY TYPE,
2025–2030 (USD MILLION) 239
TABLE 317 MEXICO: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION) 240
TABLE 318 MEXICO: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION) 240
TABLE 319 MEXICO: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 240
TABLE 320 MEXICO: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 241
TABLE 321 MEXICO: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES,
BY TYPE, 2022–2024 (USD MILLION) 241
TABLE 322 MEXICO: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES,
BY TYPE, 2025–2030 (USD MILLION) 241
TABLE 323 MEXICO: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2022–2024 (USD MILLION) 242
TABLE 324 MEXICO: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2025–2030 (USD MILLION) 242
TABLE 325 MEXICO: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2022–2024 (USD MILLION) 242
TABLE 326 MEXICO: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2025–2030 (USD MILLION) 243
TABLE 327 REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE,
2022–2024 (USD MILLION) 243
TABLE 328 REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE,
2025–2030 (USD MILLION) 244
TABLE 329 REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION) 244
TABLE 330 REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION) 244
TABLE 331 REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 245
TABLE 332 REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 245
TABLE 333 REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 245
TABLE 334 REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 246
TABLE 335 REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION) 246
TABLE 336 REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION) 246
TABLE 337 REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION) 247
TABLE 338 REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION) 247
TABLE 339 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2022–2024 (USD MILLION) 248
TABLE 340 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 248
TABLE 341 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE,
2022–2024 (USD MILLION) 248
TABLE 342 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE,
2025–2030 (USD MILLION) 249
TABLE 343 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION) 249
TABLE 344 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION) 249
TABLE 345 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 250
TABLE 346 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 250
TABLE 347 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 250
TABLE 348 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 251
TABLE 349 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022–2024 (USD MILLION) 251
TABLE 350 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025–2030 (USD MILLION) 251
TABLE 351 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022–2024 (USD MILLION) 252
TABLE 352 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025–2030 (USD MILLION) 252
TABLE 353 GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET, BY TYPE,
2022–2024 (USD MILLION) 253
TABLE 354 GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET, BY TYPE,
2025–2030 (USD MILLION) 253
TABLE 355 GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS,
BY TYPE, 2022–2024 (USD MILLION) 253
TABLE 356 GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS,
BY TYPE, 2025–2030 (USD MILLION) 254
TABLE 357 GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS,
BY TYPE, 2022–2024 (USD MILLION) 254
TABLE 358 GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS,
BY TYPE, 2025–2030 (USD MILLION) 254
TABLE 359 GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 255
TABLE 360 GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 255
TABLE 361 GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2022–2024 (USD MILLION) 255
TABLE 362 GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2025–2030 (USD MILLION) 256
TABLE 363 GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2022–2024 (USD MILLION) 256
TABLE 364 GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET, BY END USER,
2025–2030 (USD MILLION) 256
TABLE 365 REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022–2024 (USD MILLION) 257
TABLE 366 REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025–2030 (USD MILLION) 257
TABLE 367 REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022–2024 (USD MILLION) 258
TABLE 368 REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025–2030 (USD MILLION) 258
TABLE 369 REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022–2024 (USD MILLION) 258
TABLE 370 REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025–2030 (USD MILLION) 259
TABLE 371 REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022–2024 (USD MILLION) 259
TABLE 372 REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025–2030 (USD MILLION) 259
TABLE 373 REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET,
BY DISEASE TYPE, 2022–2024 (USD MILLION) 260
TABLE 374 REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET,
BY DISEASE TYPE, 2025–2030 (USD MILLION) 260
TABLE 375 REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET,
BY END USER, 2022–2024 (USD MILLION) 260
TABLE 376 REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET,
BY END USER, 2025–2030 (USD MILLION) 261
TABLE 377 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN INSULIN DELIVERY DEVICES MARKET 262
TABLE 378 INSULIN DELIVERY DEVICE MARKET: DEGREE OF COMPETITION 265
TABLE 379 INSULIN DELIVERY DEVICES MARKET: TYPE FOOTPRINT, 2024 270
TABLE 380 INSULIN DELIVERY DEVICES MARKET: REGION FOOTPRINT, 2024 271
TABLE 381 INSULIN DELIVERY DEVICES MARKET: DETAILED LIST OF
KEY STARTUPS/SMES, 2024 274
TABLE 382 INSULIN DELIVERY DEVICES MARKET: COMPETITIVE BENCHMARKING
OF KEY STARTUPS/SMES, 2024 275
TABLE 383 INSULIN DELIVERY DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–APRIL 2025 278
TABLE 384 INSULIN DELIVERY DEVICES MARKET: DEALS, JANUARY 2022–APRIL 2025 285
TABLE 385 INSULIN DELIVERY DEVICES MARKET: EXPANSIONS, JANUARY 2022–APRIL 2025 291
TABLE 386 INSULIN DELIVERY DEVICES MARKET: OTHER DEVELOPMENTS,
JANUARY 2022–APRIL 2025 294
TABLE 387 EMBECTA CORP.: BUSINESS OVERVIEW 296
TABLE 388 EMBECTA CORP.: PRODUCTS OFFERED 297
TABLE 389 EMBECTA CORP: PRODUCTS LAUNCHES & APPROVALS 298
TABLE 390 EMBECTA CORP: DEALS 298
TABLE 391 EMBECTA CORP: EXPANSIONS 299
TABLE 392 EMBECTA CORP.: OTHER DEVELOPMENTS 299
TABLE 393 NOVO NORDISK A/S: BUSINESS OVERVIEW 301
TABLE 394 NOVO NORDISK A/S: PRODUCTS OFFERED 302
TABLE 395 NOVO NORDISK A/S: PRODUCTS LAUNCHES & APPROVALS 303
TABLE 396 NOVO NORDISK A/S: DEALS 303
TABLE 397 NOVO NORDISK A/S: OTHER DEVELOPMENTS 305
TABLE 398 MEDTRONIC: BUSINESS OVERVIEW 307
TABLE 399 MEDTRONIC: PRODUCTS OFFERED 308
TABLE 400 MEDTRONIC: PRODUCT LAUNCHES & APPROVALS 309
TABLE 401 MEDTRONIC: DEALS 310
TABLE 402 MEDTRONIC: EXPANSIONS 311
TABLE 403 MEDTRONIC: OTHER DEVELOPMENTS 311
TABLE 404 SANOFI: BUSINESS OVERVIEW 313
TABLE 405 SANOFI: PRODUCTS OFFERED 314
TABLE 406 SANOFI: PRODUCT LAUNCHES & APPROVALS 315
TABLE 407 SANOFI: EXPANSIONS 315
TABLE 408 SANOFI: OTHER DEVELOPMENTS 316
TABLE 409 ELI LILLY AND COMPANY: BUSINESS OVERVIEW 318
TABLE 410 ELI LILLY AND COMPANY: PRODUCTS OFFERED 319
TABLE 411 ELI LILLY AND COMPANY: PRODUCTS LAUNCHES 320
TABLE 412 ELI LILLY AND COMPANY: DEALS 320
TABLE 413 ELI LILLY AND COMPANY: EXPANSIONS 321
TABLE 414 ELI LILLY AND COMPANY: OTHER DEVELOPMENTS 321
TABLE 415 TANDEM DIABETES CARE, INC.: BUSINESS OVERVIEW 323
TABLE 416 TANDEM DIABETES CARE, INC.: PRODUCTS OFFERED 324
TABLE 417 TANDEM DIABETES CARE, INC.: PRODUCTS LAUNCHES & APPROVALS 325
TABLE 418 TANDEM DIABETES CARE, INC.: DEALS 326
TABLE 419 INSULET CORPORATION: BUSINESS OVERVIEW 328
TABLE 420 INSULET CORPORATION: PRODUCTS LAUNCHES & APPROVALS 330
TABLE 421 INSULET CORPORATION: DEALS 332
TABLE 422 INSULET CORPORATION: EXPANSIONS 332
TABLE 423 INSULET CORPORATION: OTHER DEVELOPMENTS 333
TABLE 424 BIOCON: BUSINESS OVERVIEW 334
TABLE 425 BIOCON: PRODUCTS OFFERED 335
TABLE 426 BIOCON: DEALS 336
TABLE 427 BIOCON: OTHER DEVELOPMENTS 337
TABLE 428 F. HOFFMANN-LA ROCHE: BUSINESS OVERVIEW 338
TABLE 429 F. HOFFMANN-LA ROCHE: PRODUCTS OFFERED 339
TABLE 430 HOFFMANN-LA ROCHE LTD.: PRODUCTS LAUNCHES 340
TABLE 431 HTL-STREFA (SUBSIDIARY OF THE MTD GROUP): BUSINESS OVERVIEW 341
TABLE 432 HTL-STREFA (SUBSIDIARY OF THE MTD GROUP): PRODUCTS OFFERED 342
TABLE 433 HTL-STREFA (SUBSIDIARY OF THE MTD GROUP): DEALS 342
TABLE 434 YPSOMED: BUSINESS OVERVIEW 343
TABLE 435 YPSOMED: PRODUCTS OFFERED 344
TABLE 436 YPSOMED: PRODUCT LAUNCHES & APPROVALS 345
TABLE 437 YPSOMED: DEALS 346
TABLE 438 YPSOMED: EXPANSIONS 347
TABLE 439 YPSOMED: OTHER DEVELOPMENTS 348
TABLE 440 MEDTRUM TECHNOLOGIES INC.: BUSINESS OVERVIEW 349
TABLE 441 MEDTRUM TECHNOLOGIES INC.: PRODUCT PORTFOLIO 349
TABLE 442 TERUMO CORPORATION: BUSINESS OVERVIEW 350
TABLE 443 TERUMO CORPORATION: PRODUCTS OFFERED 351
TABLE 444 TERUMO CORPORATION: PRODUCT LAUNCHES 352
TABLE 445 TERUMO CORPORATION: DEALS 352
TABLE 446 TERUMO CORPORATION: EXPANSIONS 353
TABLE 447 TERUMO CORPORATION: OTHER DEVELOPMENTS 353
TABLE 448 WOCKHARDT LIMITED: BUSINESS OVERVIEW 354
TABLE 449 WOCKHARDT LIMITED: PRODUCTS OFFERED 355
TABLE 450 WOCKHARDT LIMITED: PRODUCTS LAUNCHES 355
TABLE 451 WOCKHARDT LIMITED: OTHER DEVELOPMENTS 356
TABLE 452 NIPRO: BUSINESS OVERVIEW 357
TABLE 453 NIPRO: PRODUCTS OFFERED 358
TABLE 454 NIPRO: EXPANSIONS 359
LIST OF FIGURES
FIGURE 1 INSULIN DELIVERY DEVICES MARKET SEGMENTATION 35
FIGURE 2 STUDY YEARS CONSIDERED 36
FIGURE 3 RESEARCH DESIGN 39
FIGURE 4 KEY DATA FROM SECONDARY SOURCES 41
FIGURE 5 PRIMARY SOURCES 42
FIGURE 6 KEY DATA FROM PRIMARY SOURCES 43
FIGURE 7 KEY INDUSTRY INSIGHTS 43
FIGURE 8 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND
DEMAND-SIDE PARTICIPANTS 44
FIGURE 9 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE,
DESIGNATION, AND REGION 44
FIGURE 10 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS 45
FIGURE 11 TOP-DOWN APPROACH 46
FIGURE 12 INSULIN DELIVERY DEVICES MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025–2030) 47
FIGURE 13 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS 48
FIGURE 14 DATA TRIANGULATION METHODOLOGY 49
FIGURE 15 INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 52
FIGURE 16 INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE,
2025 VS. 2030 (USD MILLION) 53
FIGURE 17 INSULIN DELIVERY DEVICES MARKET, BY END USER,
2025 VS. 2030 (USD MILLION) 53
FIGURE 18 GEOGRAPHICAL SNAPSHOT OF INSULIN DELIVERY DEVICES MARKET 54
FIGURE 19 INCREASING TECHNOLOGICAL ADVANCEMENTS IN INSULIN DELIVERY
DEVICES TO DRIVE MARKET 56
FIGURE 20 NORTH AMERICA ACCOUNTED FOR LARGEST SHARE OF INSULIN DELIVERY DEVICES MARKET IN 2024 57
FIGURE 21 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 58
FIGURE 22 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE
DURING FORECAST PERIOD (2025–2030) 58
FIGURE 23 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES
DURING FORECAST PERIOD 59
FIGURE 24 INSULIN DELIVERY DEVICES MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES 60
FIGURE 25 ESTIMATES OF GLOBAL PREVALENCE OF DIABETES IN 20–79-YEAR AGE GROUP, 2011–2024 (MILLION) 61
FIGURE 26 DIABETES AGE-STANDARDIZED PREVALENCE IN PEOPLE (65–99 YEARS),
BY REGION, 2024 AND 2050 (MILLION) 62
FIGURE 27 ADVANCEMENTS IN INSULIN DELIVERY DEVICES 63
FIGURE 28 FDA 510(K) APPROVAL PROCESS 73
FIGURE 29 EUROPE: CE MARK APPROVAL PROCESS FOR INSULIN DELIVERY DEVICES 75
FIGURE 30 SUMMARY OF APPROVAL, ACCESS, AND DISTRIBUTION PATHWAYS FOR NEW TECHNOLOGY USED FOR INSULIN DRUG DELIVERY DEVICES 78
FIGURE 31 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR INSULIN DELIVERY DEVICES MARKET, JANUARY 2014–DECEMBER 2024 91
FIGURE 32 TOP PATENT APPLICANT COUNTRIES FOR INSULIN DELIVERY DEVICES,
JANUARY 2014–DECEMBER 2024 92
FIGURE 33 INSULIN DELIVERY DEVICE MARKET: SUPPLY CHAIN ANALYSIS 94
FIGURE 34 INSULIN DELIVERY DEVICE: VALUE CHAIN ANALYSIS 95
FIGURE 35 INSULIN DELIVERY DEVICE MARKET: ECOSYSTEM MAPPING 96
FIGURE 36 INSULIN DELIVERY DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 98
FIGURE 37 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF END USERS 100
FIGURE 38 KEY BUYING CRITERIA FOR END USERS 101
FIGURE 39 INSULIN DELIVERY DEVICES MARKET: ADJACENT MARKET ANALYSIS 102
FIGURE 40 INVESTMENT/VENTURE CAPITAL SCENARIO IN INSULIN DELIVERY DEVICES,
2021–2023 (USD MILLION) 102
FIGURE 41 INSULIN DELIVERY DEVICES MARKET: GEOGRAPHIC SNAPSHOT 147
FIGURE 42 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET SNAPSHOT 149
FIGURE 43 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET SNAPSHOT 197
FIGURE 44 REVENUE SHARE ANALYSIS OF KEY PLAYERS, 2022–2024 (USD MILLION) 264
FIGURE 45 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 265
FIGURE 46 INSULIN DELIVERY DEVICES MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2024 268
FIGURE 47 INSULIN DELIVERY DEVICES MARKET: COMPANY FOOTPRINT, 2024 269
FIGURE 48 INSULIN DELIVERY DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 273
FIGURE 49 INSULIN DELIVERY DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 276
FIGURE 50 EV/EBITDA OF KEY VENDORS, 2024 277
FIGURE 51 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA
OF KEY VENDORS, 2024 277
FIGURE 52 R&D ASSESSMENT OF KEY PLAYERS 278
FIGURE 53 EMBECTA CORP.: COMPANY SNAPSHOT, 2024 297
FIGURE 54 NOVO NORDISK A/S: COMPANY SNAPSHOT, 2024 302
FIGURE 55 MEDTRONIC: COMPANY SNAPSHOT, 2024 308
FIGURE 56 SANOFI: COMPANY SNAPSHOT, 2024 314
FIGURE 57 ELI LILLY AND COMPANY: COMPANY SNAPSHOT, 2024 319
FIGURE 58 TANDEM DIABETES CARE, INC.: COMPANY SNAPSHOT, 2024 324
FIGURE 59 INSULET CORPORATION: COMPANY SNAPSHOT, 2024 329
FIGURE 60 BIOCON: COMPANY SNAPSHOT, 2024 335
FIGURE 61 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT, 2024 339
FIGURE 62 YPSOMED: COMPANY SNAPSHOT, 2024 344
FIGURE 63 TERUMO CORPORATION: COMPANY SNAPSHOT, 2024 351
FIGURE 64 WOCKHARDT LIMITED: COMPANY SNAPSHOT, 2024 355
FIGURE 65 NIPRO: COMPANY SNAPSHOT, 2024 358
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11